Kevin Hageman
@Factor_XII
Hospitalist via @gtown_medres & @PCOMGeorgia - #MedEd ; clinical/diagnostic reasoning, patient communication/education & transitions of care. Tweets/RT my own.
All this “innovation” and “AI is going to take over medicine” and I can’t even get an accurate patient weight.
The first person to develop a urinary procalprotectin is gonna be a billionaire
Great to see this in @JHospMedicine @SocietyHospMed Offer naltrexone to patients with cirrhosis and etoh use disorder!!
Attendings trying to explain the actions of Interns on Day 1
Nice review article published this month in The Rheumatology Oxford Journal Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review👇#myositis #Rheumatology #MedTwitter Full Ref included below
For interns/residents and even attendings - you don’t have blindly follow consultant recs, especially if you don’t understand them. If something isn’t clear to me, I’ll say: “Just for my understanding, can you explain xyz?” “I’m genuinely curious why x and not y?” Just ask!
Hot take: If you haven’t practiced inpatient medicine in some capacity in the past decade, you should not have admitting privileges. And I think that’s being generous. (I say this from a safety, resource utilization, and systems perspective)
I’ll Venmo $5 to the first person who can correctly guess the lab assay associated with this value.
Mobility is one of the most important - and most overlooked - ICU interventions. One challenge is its isn’t always obvious what mobility level a patient has achieved. I built these “flip books” using the JH-HLM scale to indicate (& motivate) mobility in every patients room.
Chest pain, normal ECG, and serial undetectable high sensitivity troponins. Should we do further testing? hqmeded-ecg.blogspot.com/2025/05/chest-…
The Vitamin D research has got to stop. @DOGE stop cutting our other research but feel free to cancel this garbage! thelancet.com/journals/landi…
What really happens when patients stop GLP-1s like semaglutide or tirzepatide? A new systematic review & meta-analysis in Obesity Reviews has answers—and they’re critical for anyone treating obesity as a chronic disease. TLDR: "Discontinuation of GLP-1RA treatment leads to…
if your attending dresses like this, you better do a complete neuro exam
Just because an intervention exists does not mean you have to offer it. You are the expert. It’s your job to determine appropriateness. Eg) 1) BKA to a frail, contractured, 100 year old 2) PEG in advanced dementia 3) Chemo “when they get stronger”